The global advanced cancer diagnostics market was valued at USD 58.09 billion in 2024 and is forecasted to grow at a CAGR of 9.1% through 2034. The market’s structural segmentation by technology, application, and end-user reveals a rapidly diversifying ecosystem characterized by product differentiation, value chain optimization, and clinical integration. Continuous innovation across...